Colangiocarcinoma (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Colangiocarcinoma" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
1,684th place
1,095th place
5th place
5th place
low place
low place
3,595th place
3,865th place
low place
6,474th place
cancer.gov
- «Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Health Professional Version». National Cancer Institute. 14 de março de 2018. Consultado em 26 de maio de 2020
- «NCI Dictionary of Cancer Terms». National Cancer Institute (em inglês). 2 de fevereiro de 2011. Consultado em 4 de junho de 2020
- «Bile Duct Cancer (Cholangiocarcinoma) Symptoms, Tests, Prognosis, and Stages». National Cancer Institute (em inglês). 5 de julho de 2018. Consultado em 1 de junho de 2020
- Cancer Statistics Home Page — National Cancer Institute
doi.org
dx.doi.org
- Benavides, M; Antón, A; Gallego, J; Gómez, MA; Jiménez-Gordo, A; La Casta, A; Laquente, B; Macarulla, T; Rodríguez-Mowbray, JR; Maurel, J (dezembro de 2015). «Biliary tract cancers: SEOM clinical guidelines». Clinical & Translational Oncology. 17 (12): 982–7. PMC 4689747
. PMID 26607930. doi:10.1007/s12094-015-1436-2 - Steele, JA; Richter, CH; Echaubard, P; Saenna, P; Stout, V; Sithithaworn, P; Wilcox, BA (17 de maio de 2018). «Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis». Infectious Diseases of Poverty. 7 (1). 44 páginas. PMC 5956617. PMID 29769113. doi:10.1186/s40249-018-0434-3
- Razumilava, N; Gores, GJ (21 de junho de 2014). «Cholangiocarcinoma». Lancet. 383 (9935): 2168–79. PMC 4069226. PMID 24581682. doi:10.1016/S0140-6736(13)61903-0
- Bridgewater, JA; Goodman, KA; Kalyan, A; Mulcahy, MF (2016). «Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling». American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 35 (36): e194–203. PMID 27249723. doi:10.1200/EDBK_160831
- Nagorney D, Donohue J, Farnell M, Schleck C, Ilstrup D (1993). «Outcomes after curative resections of cholangiocarcinoma». Arch Surg. 128 (8): 871–7; discussão em 877–9. PMID 8393652. doi:10.1001/archsurg.1993.01420200045008
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406. PMID 8857851. doi:10.1097/00000658-199610000-00005
- «Risk factors for biliary tract carcinogenesis». Ann Oncol. 10 (4): 308–11. 1999. PMID 10436847. doi:10.1023/A:1008313809752
- Estudos epidemiológicos que abordaram a incidência de colangiocarcinoma em pessoas com colangite esclerosante primária incluem os seguintes:
- Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzén H, Almer S, Granath F, Broomé U (2002). «Hepatic and extrahepatic malignancies in primary sclerosing cholangitis». J Hepatol. 36 (3): 321–7. PMID 11867174. doi:10.1016/S0168-8278(01)00288-4
- Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF (janeiro de 1991). «Cholangiocarcinoma complicating primary sclerosing cholangitis». Annals of Surgery. 213 (1): 21–5. PMC 1358305. PMID 1845927. doi:10.1097/00000658-199101000-00004
- Watanapa P, Watanapa W (2002). «Liver fluke-associated cholangiocarcinoma». Br J Surg. 89 (8): 962–70. PMID 12153620. doi:10.1046/j.1365-2168.2002.02143.x
- Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, Brindley PJ (2007). «Liver fluke induces cholangiocarcinoma». PLoS Medicine. 4 (7): 1148–1155. PMC 1913093. PMID 17622191. doi:10.1371/journal.pmed.0040201
- Sripa B, Kaewkes S, Intapan PM, Maleewong W, Brindley PJ (2010). «Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control». Adv Parasitol. 72: 305–350. PMID 20624536. doi:10.1016/S0065-308X(10)72011-X
- Rustagi T, Dasanu CA (2012). «Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates». J Gastrointest Cancer. 43 (2): 137–147. PMID 21597894. doi:10.1007/s12029-011-9284-y
- Hong ST, Fang Y (2012). «Clonorchis sinensis and clonorchiasis, an update». Parasitol Int. 61 (1): 17–24. PMID 21741496. doi:10.1016/j.parint.2011.06.007
- Sripa, B; Tangkawattana, S; Sangnikul, T (agosto de 2017). «The Lawa model: A sustainable, integrated opisthorchiasis control program using the EcoHealth approach in the Lawa Lake region of Thailand». Parasitology international. 66 (4): 346–354. PMC 5443708. PMID 27890720. doi:10.1016/j.parint.2016.11.013
- Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H (2000). «Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis». Cancer. 88 (11): 2471–7. PMID 10861422. doi:10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T
- Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T (2004). «Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma». Cancer Sci. 95 (7): 592–5. PMID 15245596. doi:10.1111/j.1349-7006.2004.tb02492.x
- Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (março de 2005). «Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study». Gastroenterology. 128 (3): 620–6. PMID 15765398. doi:10.1053/j.gastro.2004.12.048
- Sorensen H, Friis S, Olsen J, Thulstrup A, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J (1998). «Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark». Hepatology. 28 (4): 921–5. PMID 9755226. doi:10.1002/hep.510280404
- «Role of Bacteria in Oncogenesis». 23 (4). 2010: 837–857. ISSN 0893-8512. PMC 2952975. PMID 20930075. doi:10.1128/CMR.00012-10
- Lipsett P, Pitt H, Colombani P, Boitnott J, Cameron J (1994). «Choledochal cyst disease. A changing pattern of presentation». Ann Surg. 220 (5): 644–52. PMC 1234452. PMID 7979612. doi:10.1097/00000658-199411000-00007
- Dayton M, Longmire W, Tompkins R (1983). «Caroli's Disease: a premalignant condition?». Am J Surg. 145 (1): 41–8. PMID 6295196. doi:10.1016/0002-9610(83)90164-2
- Mecklin J, Järvinen H, Virolainen M (1992). «The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma». Cancer. 69 (5): 1112–4. PMID 1310886. doi:10.1002/cncr.2820690508
- Lee S, Kim M, Lee S, Jang S, Song M, Kim K, Kim H, Seo D, Song D, Yu E, Lee S, Min Y (2004). «Clinicopathologic review of 58 patients with biliary papillomatosis». Cancer. 100 (4): 783–93. PMID 14770435. doi:10.1002/cncr.20031
- Lee C, Wu C, Chen G (2002). «What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?». J Gastroenterol Hepatol. 17 (9): 1015–20. PMID 12167124. doi:10.1046/j.1440-1746.2002.02779.x
- Su C, Shyr Y, Lui W, P'Eng F (1997). «Hepatolithiasis associated with cholangiocarcinoma». Br J Surg. 84 (7): 969–73. PMID 9240138. doi:10.1002/bjs.1800840717
- Donato F, Gelatti U, Tagger A, Favret M, Ribero M, Callea F, Martelli C, Savio A, Trevisi P, Nardi G (2001). «Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy». Cancer Causes Control. 12 (10): 959–64. PMID 11808716. doi:10.1023/A:1013747228572
- Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S (2003). «Thorotrast-induced cholangiocarcinoma: case report». Abdom Imaging. 28 (1): 72–4. PMID 12483389. doi:10.1007/s00261-001-0148-y
- Zhu A, Lauwers G, Tanabe K (2004). «Cholangiocarcinoma in association with Thorotrast exposure». J Hepatobiliary Pancreat Surg. 11 (6): 430–3. PMID 15619021. doi:10.1007/s00534-004-0924-5
- Lipshutz, GS; Brennan, TV; Warren, RS (novembro de 2002). «Thorotrast-induced liver neoplasia: a collective review». Journal of the American College of Surgeons. 195 (5): 713–8. PMID 12437262. doi:10.1016/S1072-7515(02)01287-5
- Klatskin G (1965). «Adenocarcinoma Of The Hepatic Duct At Its Bifurcation Within The Porta Hepatis. An Unusual Tumor With Distinctive Clinical And Pathological Features». Am J Med. 32 (2): 241–56. PMID 14256720. doi:10.1016/0002-9343(65)90178-6
- Roskams T (2006). «Liver stem cells and their implication in hepatocellular and cholangiocarcinoma». Oncogene. 25 (27): 3818–22. PMID 16799623. doi:10.1038/sj.onc.1209558
- Liu C, Wang J, Ou Q (2004). «Possible stem cell origin of human cholangiocarcinoma». World J Gastroenterol. 10 (22): 3374–6. PMID 15484322. doi:10.3748/wjg.v10.i22.3374
- Sirica A (2005). «Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy». Hepatology. 41 (1): 5–15. PMID 15690474. doi:10.1002/hep.20537
- Holzinger F, Z'graggen K, Büchler M (1999). «Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma». Ann Oncol. 10 (Suppl 4): 122–6. PMID 10436802. doi:10.1023/A:1008321710719
- Gores G (2003). «Cholangiocarcinoma: current concepts and insights». 37 (5): 961–9. PMID 12717374. doi:10.1053/jhep.2003.50200
- de Groen P, Gores G, LaRusso N, Gunderson L, Nagorney D (1999). «Biliary tract cancers». N Engl J Med. 341 (18): 1368–78. PMID 10536130. doi:10.1056/NEJM199910283411807
- Henson DE, Albores-Saavedra J, Corle D (setembro de 1992). «Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates». Cancer. 70 (6): 1498–501. PMID 1516001. doi:10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C
- Estudos do desempenho de marcadores séricos para colangiocarcinoma (como o antígeno carcinoembrionário e CA19-9) em pacientes com e sem colangite esclerosante primária incluem os seguintes:
- Nehls O, Gregor M, Klump B (2004). «Serum and bile markers for cholangiocarcinoma». Semin Liver Dis. 24 (2): 139–54. PMID 15192787. doi:10.1055/s-2004-828891
- Saini S (1997). «Imaging of the hepatobiliary tract». N Engl J Med. 336 (26): 1889–94. PMID 9197218. doi:10.1056/NEJM199706263362607
- Bloom C, Langer B, Wilson S (1999). «Role of US in the detection, characterization, and staging of cholangiocarcinoma». Radiographics. 19 (5): 1199–218. PMID 10489176. doi:10.1148/radiographics.19.5.g99se081199
- Valls C, Gumà A, Puig I, Sanchez A, Andía E, Serrano T, Figueras J (2000). «Intrahepatic peripheral cholangiocarcinoma: CT evaluation». Abdom Imaging. 25 (5): 490–6. PMID 10931983. doi:10.1007/s002610000079
- Tillich M, Mischinger H, Preisegger K, Rabl H, Szolar D (1998). «Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma». AJR Am J Roentgenol. 171 (3): 651–8. PMID 9725291. doi:10.2214/ajr.171.3.9725291
- Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y (1999). «Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI». 23. 5 (670–7). PMID 10524843. doi:10.1097/00004728-199909000-00004
- Sugiyama M, Hagi H, Atomi Y, Saito M (1997). «Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography». Abdom Imaging. 22 (4): 434–8. PMID 9157867. doi:10.1007/s002619900227
- Schwartz L, Coakley F, Sun Y, Blumgart L, Fong Y, Panicek D (1998). «Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography». AJR Am J Roentgenol. 170 (6): 1491–5. PMID 9609160. doi:10.2214/ajr.170.6.9609160
- Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G (2000). «Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures». Gut. 46 (1): 103–6. PMC 1727781. PMID 10601064. doi:10.1136/gut.46.1.103
- Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E (2003). «Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography». World J Surg. 27 (3): 278–83. PMID 12607051. doi:10.1007/s00268-002-6701-1
- Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M (2000). «Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings». Am J Gastroenterol. 95 (2): 432–40. PMID 10685746. doi:10.1111/j.1572-0241.2000.01763.x
- Szklaruk J, Tamm E, Charnsangavej C (2002). «Preoperative imaging of biliary tract cancers». Surg Oncol Clin N Am. 11 (4): 865–76. PMID 12607576. doi:10.1016/S1055-3207(02)00032-7
- Weber S, DeMatteo R, Fong Y, Blumgart L, Jarnagin W (2002). «Staging Laparoscopy in Patients With Extrahepatic Biliary Carcinoma: Analysis of 100 Patients». Ann Surg. 235 (3): 392–9. PMC 1422445. PMID 11882761. doi:10.1097/00000658-200203000-00011
- Callery M, Strasberg S, Doherty G, Soper N, Norton J (1997). «Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy». J Am Coll Surg. 185 (1): 33–9. PMID 9208958. doi:10.1016/s1072-7515(97)00003-3
- Länger F, von Wasielewski R, Kreipe HH (2004). «Bedeutung der Immunhistochemie für die Diagnose des Cholangiokarzinoms» [Importância da imuno-histoquímica para o diagnóstico de colangiocarcinoma]. Pathologe (em alemão). 27 (4): 244–50. PMID 16758167. doi:10.1007/s00292-006-0836-z
- Zervos E, Osborne D, Goldin S, Villadolid D, Thometz D, Durkin A, Carey L, Rosemurgy A (2005). «Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach». Am J Surg. 190 (5): 810–5. PMID 16226963. doi:10.1016/j.amjsurg.2005.07.025
- Tsao J, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi R, Braasch J, Dugan J (2000). «Management of Hilar Cholangiocarcinoma: Comparison of an American and a Japanese Experience». Ann Surg. 232 (2): 166–74. PMC 1421125. PMID 10903592. doi:10.1097/00000658-200008000-00003
- Su C, Tsay S, Wu C, Shyr Y, King K, Lee C, Lui W, Liu T, P'eng F (1996). «Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma». Ann Surg. 223 (4): 384–94. PMC 1235134. PMID 8633917. doi:10.1097/00000658-199604000-00007
- C. B. Rosen; J. K. Heimbach; G. J. Gores (2008). «Surgery for cholangiocarcinoma: the role of liver transplantation». The Official Journal of the International Hepato Pancreato Biliary Association. 10 (3): 186–9. PMC 2504373. PMID 18773052. doi:10.1080/13651820801992542
- Heimbach JK, Gores GJ, Haddock MG, et al. (dezembro de 2006). «Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma». Transplantation. 82 (12): 1703–7. PMID 17198263. doi:10.1097/01.tp.0000253551.43583.d1
- Kuhlmann, Jan B.; Blum, Hubert E. (maio de 2013). «Locoregional therapy for cholangiocarcinoma». Current Opinion in Gastroenterology. 29 (3): 324–8. ISSN 0267-1379. PMID 23337933. doi:10.1097/MOG.0b013e32835d9dea
- Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K (2000). «Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma». Int J Radiat Oncol Biol Phys. 46 (3): 581–7. PMID 10701737. doi:10.1016/S0360-3016(99)00472-1
- Alden M, Mohiuddin M (1994). «The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer». Int J Radiat Oncol Biol Phys. 28 (4): 945–51. PMID 8138448. doi:10.1016/0360-3016(94)90115-5
- González González D, Gouma D, Rauws E, van Gulik T, Bosma A, Koedooder C (1999). «Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma». Ann Oncol. 10 (Suppl 4): 215–20. PMID 10436826. doi:10.1023/A:1008339709327
- Pitt H, Nakeeb A, Abrams R, Coleman J, Piantadosi S, Yeo C, Lillemore K, Cameron J (1995). «Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival». Ann Surg. 221 (6): 788–97; discussão em 797–8. PMC 1234714. PMID 7794082. doi:10.1097/00000658-199506000-00017
- Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T (2002). «Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma». Cancer. 95 (8): 1685–95. PMID 12365016. doi:10.1002/cncr.10831
- Vauthey J, Blumgart L (1994). «Recent advances in the management of cholangiocarcinomas». Semin. Liver Dis. 14 (2): 109–14. PMID 8047893. doi:10.1055/s-2007-1007302
- Glimelius B, Hoffman K, Sjödén P, Jacobsson G, Sellström H, Enander L, Linné T, Svensson C (1996). «Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer». Ann Oncol. 7 (6): 593–600. PMID 8879373. doi:10.1093/oxfordjournals.annonc.a010676
- Choi C, Choi I, Seo J, Kim B, Kim J, Kim C, Um S, Kim J, Kim Y (2000). «Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas». Am J Clin Oncol. 23 (4): 425–8. PMID 10955877. doi:10.1097/00000421-200008000-00023
- Park J, Oh S, Kim S, Kwon H, Kim J, Jin-Kim H, Kim Y (2005). «Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study». Jpn J Clin Oncol. 35 (2): 68–73. PMID 15709089. doi:10.1093/jjco/hyi021
- Giuliani F, Gebbia V, Maiello E, Borsellino N, Bajardi E, Colucci G (2006). «Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)». Ann Oncol. 17 (Suppl 7): vii73–7. PMID 16760299. doi:10.1093/annonc/mdl956
- Knox J, Hedley D, Oza A, Feld R, Siu L, Chen E, Nematollahi M, Pond G, Zhang J, Moore M (2005). «Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial». J Clin Oncol. 23 (10): 2332–8. PMID 15800324. doi:10.1200/JCO.2005.51.008
- Philip P, Mahoney M, Allmer C, Thomas J, Pitot H, Kim G, Donehower R, Fitch T, Picus J, Erlichman C (2006). «Phase II study of erlotinib in patients with advanced biliary cancer». J Clin Oncol. 24 (19): 3069–74. PMID 16809731. doi:10.1200/JCO.2005.05.3579
- Bonet Beltrán M, Allal AS, Gich I,; et al. (2012). «Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies». Cancer Treat Rev. 38 (2): 111–119. PMID 21652148. doi:10.1016/j.ctrv.2011.05.003
- Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF (2016). «Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling». American Society of Clinical Oncology Educational Book. 36 (36): e194–e203. PMID 27249723. doi:10.1200/EDBK_160831
- Yamamoto M, Takasaki K, Yoshikawa T (1999). «Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma». Japanese Journal of Clinical Oncology. 29 (3): 147–50. PMID 10225697. doi:10.1093/jjco/29.3.147
- Farley D, Weaver A, Nagorney D (1995). «"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention». Mayo Clin Proc. 70 (5): 425–9. PMID 7537346. doi:10.4065/70.5.425
- Grove MK, Hermann RE, Vogt DP, Broughan TA (1991). «Role of radiation after operative palliation in cancer of the proximal bile ducts». Am J Surg. 161 (4): 454–58. PMID 1709795. doi:10.1016/0002-9610(91)91111-U
- Estudos de resultados cirúrgicos em colangiocarcinoma distal incluem:
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406. PMID 8857851. doi:10.1097/00000658-199610000-00005
- Estudos de desfecho em colangiocarcinoma intra-hepático incluem:
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406. PMID 8857851. doi:10.1097/00000658-199610000-00005
- As estimativas de sobrevida após cirurgia para colangiocarcinoma peri-hilar incluem:
- Burke E, Jarnagin W, Hochwald S, Pisters P, Fong Y, Blumgart L (1998). «Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system». Ann Surg. 228 (3): 385–94. PMC 1191497. PMID 9742921. doi:10.1097/00000658-199809000-00011
- Kaya M, de Groen P, Angulo P, Nagorney D, Gunderson L, Gores G, Haddock M, Lindor K (2001). «Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience». Am J Gastroenterol. 96 (4): 1164–9. PMID 11316165. doi:10.1111/j.1572-0241.2001.03696.x
- Nakeeb A, Tran K, Black M, Erickson B, Ritch P, Quebbeman E, Wilson S, Demeure M, Rilling W, Dua K, Pitt H (2002). «Improved survival in resected biliary malignancies». Surgery. 132 (4): 555–63; discussão em 563–4. PMID 12407338. doi:10.1067/msy.2002.127555
- Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (dezembro de 2002). «Changing international trends in mortality rates for liver, biliary and pancreatic tumours». Journal of Hepatology. 37 (6): 806–13. PMID 12445422. doi:10.1016/S0168-8278(02)00297-0
- Landis S, Murray T, Bolden S, Wingo P (1998). «Cancer statistics, 1998». CA Cancer J Clin. 48 (1): 6–29. PMID 9449931. doi:10.3322/canjclin.48.1.6
- Vauthey JN, Blumgart LH (maio de 1994). «Recent advances in the management of cholangiocarcinomas». Seminars in Liver Disease. 14 (2): 109–14. PMID 8047893. doi:10.1055/s-2007-1007302
- Múltiplos estudos independentes documentaram um aumento constante na incidência mundial de colangiocarcinoma. Alguns artigos de periódicos relevantes incluem:
- Patel T (maio de 2002). «Worldwide trends in mortality from biliary tract malignancies». BMC Cancer. 2 (10). PMC 113759. PMID 11991810. doi:10.1186/1471-2407-2-10
- Patel T (maio de 2002). «Worldwide trends in mortality from biliary tract malignancies». BMC Cancer. 2 (10). PMC 113759
- Burke E, Jarnagin W, Hochwald S, Pisters P, Fong Y, Blumgart L (1998). «Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system». Ann Surg. 228 (3): 385–94. PMC 1191497
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406
emedicine.com
- Darwin PE, Kennedy A. Colangiocarcinoma no eMedicine
iarc.fr
publications.iarc.fr
- Bosman, Frank T. (2014). «Chapter Chapter 5.6: Liver cancer». In: Stewart, Bernard W.; Wild, Christopher P. World Cancer Report. [S.l.]: the International Agency for Research on Cancer, World Health Organization. p. Chapter 5.6. ISBN 978-92-832-0443-5
keckmedicine.org
surgery.keckmedicine.org
- «Bile Duct Cancer». USC Surgery (em inglês). Keck Medicine Web Services. Consultado em 18 de maio de 2020
nccn.org
- «National Comprehensive Cancer Network (NCCN) guidelines on evaluation and treatment of hepatobiliary malignancies» (PDF). NCCN. Consultado em 19 de agosto de 2018
nih.gov
ncbi.nlm.nih.gov
- Benavides, M; Antón, A; Gallego, J; Gómez, MA; Jiménez-Gordo, A; La Casta, A; Laquente, B; Macarulla, T; Rodríguez-Mowbray, JR; Maurel, J (dezembro de 2015). «Biliary tract cancers: SEOM clinical guidelines». Clinical & Translational Oncology. 17 (12): 982–7. PMC 4689747. PMID 26607930. doi:10.1007/s12094-015-1436-2
- Steele, JA; Richter, CH; Echaubard, P; Saenna, P; Stout, V; Sithithaworn, P; Wilcox, BA (17 de maio de 2018). «Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis». Infectious Diseases of Poverty. 7 (1). 44 páginas. PMC 5956617. PMID 29769113. doi:10.1186/s40249-018-0434-3
- Razumilava, N; Gores, GJ (21 de junho de 2014). «Cholangiocarcinoma». Lancet. 383 (9935): 2168–79. PMC 4069226. PMID 24581682. doi:10.1016/S0140-6736(13)61903-0
- Bridgewater, JA; Goodman, KA; Kalyan, A; Mulcahy, MF (2016). «Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling». American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 35 (36): e194–203. PMID 27249723. doi:10.1200/EDBK_160831
- Nagorney D, Donohue J, Farnell M, Schleck C, Ilstrup D (1993). «Outcomes after curative resections of cholangiocarcinoma». Arch Surg. 128 (8): 871–7; discussão em 877–9. PMID 8393652. doi:10.1001/archsurg.1993.01420200045008
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406. PMID 8857851. doi:10.1097/00000658-199610000-00005
- «Risk factors for biliary tract carcinogenesis». Ann Oncol. 10 (4): 308–11. 1999. PMID 10436847. doi:10.1023/A:1008313809752
- Estudos epidemiológicos que abordaram a incidência de colangiocarcinoma em pessoas com colangite esclerosante primária incluem os seguintes:
- Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzén H, Almer S, Granath F, Broomé U (2002). «Hepatic and extrahepatic malignancies in primary sclerosing cholangitis». J Hepatol. 36 (3): 321–7. PMID 11867174. doi:10.1016/S0168-8278(01)00288-4
- Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF (janeiro de 1991). «Cholangiocarcinoma complicating primary sclerosing cholangitis». Annals of Surgery. 213 (1): 21–5. PMC 1358305. PMID 1845927. doi:10.1097/00000658-199101000-00004
- Watanapa P, Watanapa W (2002). «Liver fluke-associated cholangiocarcinoma». Br J Surg. 89 (8): 962–70. PMID 12153620. doi:10.1046/j.1365-2168.2002.02143.x
- Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, Brindley PJ (2007). «Liver fluke induces cholangiocarcinoma». PLoS Medicine. 4 (7): 1148–1155. PMC 1913093. PMID 17622191. doi:10.1371/journal.pmed.0040201
- Sripa B, Kaewkes S, Intapan PM, Maleewong W, Brindley PJ (2010). «Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control». Adv Parasitol. 72: 305–350. PMID 20624536. doi:10.1016/S0065-308X(10)72011-X
- Rustagi T, Dasanu CA (2012). «Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates». J Gastrointest Cancer. 43 (2): 137–147. PMID 21597894. doi:10.1007/s12029-011-9284-y
- Hong ST, Fang Y (2012). «Clonorchis sinensis and clonorchiasis, an update». Parasitol Int. 61 (1): 17–24. PMID 21741496. doi:10.1016/j.parint.2011.06.007
- Sripa, B; Tangkawattana, S; Sangnikul, T (agosto de 2017). «The Lawa model: A sustainable, integrated opisthorchiasis control program using the EcoHealth approach in the Lawa Lake region of Thailand». Parasitology international. 66 (4): 346–354. PMC 5443708. PMID 27890720. doi:10.1016/j.parint.2016.11.013
- Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H (2000). «Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis». Cancer. 88 (11): 2471–7. PMID 10861422. doi:10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T
- Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T (2004). «Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma». Cancer Sci. 95 (7): 592–5. PMID 15245596. doi:10.1111/j.1349-7006.2004.tb02492.x
- Lu H, Ye M, Thung S, Dash S, Gerber M (2000). «Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients». Chin Med J (Engl). 113 (12): 1138–41. PMID 11776153
- Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (março de 2005). «Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study». Gastroenterology. 128 (3): 620–6. PMID 15765398. doi:10.1053/j.gastro.2004.12.048
- Sorensen H, Friis S, Olsen J, Thulstrup A, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J (1998). «Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark». Hepatology. 28 (4): 921–5. PMID 9755226. doi:10.1002/hep.510280404
- «Role of Bacteria in Oncogenesis». 23 (4). 2010: 837–857. ISSN 0893-8512. PMC 2952975. PMID 20930075. doi:10.1128/CMR.00012-10
- Lipsett P, Pitt H, Colombani P, Boitnott J, Cameron J (1994). «Choledochal cyst disease. A changing pattern of presentation». Ann Surg. 220 (5): 644–52. PMC 1234452. PMID 7979612. doi:10.1097/00000658-199411000-00007
- Dayton M, Longmire W, Tompkins R (1983). «Caroli's Disease: a premalignant condition?». Am J Surg. 145 (1): 41–8. PMID 6295196. doi:10.1016/0002-9610(83)90164-2
- Mecklin J, Järvinen H, Virolainen M (1992). «The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma». Cancer. 69 (5): 1112–4. PMID 1310886. doi:10.1002/cncr.2820690508
- Lee S, Kim M, Lee S, Jang S, Song M, Kim K, Kim H, Seo D, Song D, Yu E, Lee S, Min Y (2004). «Clinicopathologic review of 58 patients with biliary papillomatosis». Cancer. 100 (4): 783–93. PMID 14770435. doi:10.1002/cncr.20031
- Lee C, Wu C, Chen G (2002). «What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?». J Gastroenterol Hepatol. 17 (9): 1015–20. PMID 12167124. doi:10.1046/j.1440-1746.2002.02779.x
- Su C, Shyr Y, Lui W, P'Eng F (1997). «Hepatolithiasis associated with cholangiocarcinoma». Br J Surg. 84 (7): 969–73. PMID 9240138. doi:10.1002/bjs.1800840717
- Donato F, Gelatti U, Tagger A, Favret M, Ribero M, Callea F, Martelli C, Savio A, Trevisi P, Nardi G (2001). «Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy». Cancer Causes Control. 12 (10): 959–64. PMID 11808716. doi:10.1023/A:1013747228572
- Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S (2003). «Thorotrast-induced cholangiocarcinoma: case report». Abdom Imaging. 28 (1): 72–4. PMID 12483389. doi:10.1007/s00261-001-0148-y
- Zhu A, Lauwers G, Tanabe K (2004). «Cholangiocarcinoma in association with Thorotrast exposure». J Hepatobiliary Pancreat Surg. 11 (6): 430–3. PMID 15619021. doi:10.1007/s00534-004-0924-5
- Lipshutz, GS; Brennan, TV; Warren, RS (novembro de 2002). «Thorotrast-induced liver neoplasia: a collective review». Journal of the American College of Surgeons. 195 (5): 713–8. PMID 12437262. doi:10.1016/S1072-7515(02)01287-5
- Klatskin G (1965). «Adenocarcinoma Of The Hepatic Duct At Its Bifurcation Within The Porta Hepatis. An Unusual Tumor With Distinctive Clinical And Pathological Features». Am J Med. 32 (2): 241–56. PMID 14256720. doi:10.1016/0002-9343(65)90178-6
- Roskams T (2006). «Liver stem cells and their implication in hepatocellular and cholangiocarcinoma». Oncogene. 25 (27): 3818–22. PMID 16799623. doi:10.1038/sj.onc.1209558
- Liu C, Wang J, Ou Q (2004). «Possible stem cell origin of human cholangiocarcinoma». World J Gastroenterol. 10 (22): 3374–6. PMID 15484322. doi:10.3748/wjg.v10.i22.3374
- Sell S, Dunsford H (1989). «Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma». Am J Pathol. 134 (6): 1347–63. PMC 1879951. PMID 2474256
- Sirica A (2005). «Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy». Hepatology. 41 (1): 5–15. PMID 15690474. doi:10.1002/hep.20537
- Holzinger F, Z'graggen K, Büchler M (1999). «Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma». Ann Oncol. 10 (Suppl 4): 122–6. PMID 10436802. doi:10.1023/A:1008321710719
- Gores G (2003). «Cholangiocarcinoma: current concepts and insights». 37 (5): 961–9. PMID 12717374. doi:10.1053/jhep.2003.50200
- de Groen P, Gores G, LaRusso N, Gunderson L, Nagorney D (1999). «Biliary tract cancers». N Engl J Med. 341 (18): 1368–78. PMID 10536130. doi:10.1056/NEJM199910283411807
- Henson DE, Albores-Saavedra J, Corle D (setembro de 1992). «Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates». Cancer. 70 (6): 1498–501. PMID 1516001. doi:10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C
- Estudos do desempenho de marcadores séricos para colangiocarcinoma (como o antígeno carcinoembrionário e CA19-9) em pacientes com e sem colangite esclerosante primária incluem os seguintes:
- Nehls O, Gregor M, Klump B (2004). «Serum and bile markers for cholangiocarcinoma». Semin Liver Dis. 24 (2): 139–54. PMID 15192787. doi:10.1055/s-2004-828891
- Saini S (1997). «Imaging of the hepatobiliary tract». N Engl J Med. 336 (26): 1889–94. PMID 9197218. doi:10.1056/NEJM199706263362607
- Sharma M, Ahuja V (1999). «Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective». Trop Gastroenterol. 20 (4): 167–9. PMID 10769604
- Bloom C, Langer B, Wilson S (1999). «Role of US in the detection, characterization, and staging of cholangiocarcinoma». Radiographics. 19 (5): 1199–218. PMID 10489176. doi:10.1148/radiographics.19.5.g99se081199
- Valls C, Gumà A, Puig I, Sanchez A, Andía E, Serrano T, Figueras J (2000). «Intrahepatic peripheral cholangiocarcinoma: CT evaluation». Abdom Imaging. 25 (5): 490–6. PMID 10931983. doi:10.1007/s002610000079
- Tillich M, Mischinger H, Preisegger K, Rabl H, Szolar D (1998). «Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma». AJR Am J Roentgenol. 171 (3): 651–8. PMID 9725291. doi:10.2214/ajr.171.3.9725291
- Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y (1999). «Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI». 23. 5 (670–7). PMID 10524843. doi:10.1097/00004728-199909000-00004
- Sugiyama M, Hagi H, Atomi Y, Saito M (1997). «Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography». Abdom Imaging. 22 (4): 434–8. PMID 9157867. doi:10.1007/s002619900227
- Schwartz L, Coakley F, Sun Y, Blumgart L, Fong Y, Panicek D (1998). «Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography». AJR Am J Roentgenol. 170 (6): 1491–5. PMID 9609160. doi:10.2214/ajr.170.6.9609160
- Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G (2000). «Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures». Gut. 46 (1): 103–6. PMC 1727781. PMID 10601064. doi:10.1136/gut.46.1.103
- Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E (2003). «Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography». World J Surg. 27 (3): 278–83. PMID 12607051. doi:10.1007/s00268-002-6701-1
- Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M (2000). «Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings». Am J Gastroenterol. 95 (2): 432–40. PMID 10685746. doi:10.1111/j.1572-0241.2000.01763.x
- Freeman M, Sielaff T (2003). «A modern approach to malignant hilar biliary obstruction». Rev Gastroenterol Disord. 3 (4): 187–201. PMID 14668691
- Szklaruk J, Tamm E, Charnsangavej C (2002). «Preoperative imaging of biliary tract cancers». Surg Oncol Clin N Am. 11 (4): 865–76. PMID 12607576. doi:10.1016/S1055-3207(02)00032-7
- Weber S, DeMatteo R, Fong Y, Blumgart L, Jarnagin W (2002). «Staging Laparoscopy in Patients With Extrahepatic Biliary Carcinoma: Analysis of 100 Patients». Ann Surg. 235 (3): 392–9. PMC 1422445. PMID 11882761. doi:10.1097/00000658-200203000-00011
- Callery M, Strasberg S, Doherty G, Soper N, Norton J (1997). «Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy». J Am Coll Surg. 185 (1): 33–9. PMID 9208958. doi:10.1016/s1072-7515(97)00003-3
- Länger F, von Wasielewski R, Kreipe HH (2004). «Bedeutung der Immunhistochemie für die Diagnose des Cholangiokarzinoms» [Importância da imuno-histoquímica para o diagnóstico de colangiocarcinoma]. Pathologe (em alemão). 27 (4): 244–50. PMID 16758167. doi:10.1007/s00292-006-0836-z
- Zervos E, Osborne D, Goldin S, Villadolid D, Thometz D, Durkin A, Carey L, Rosemurgy A (2005). «Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach». Am J Surg. 190 (5): 810–5. PMID 16226963. doi:10.1016/j.amjsurg.2005.07.025
- Tsao J, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi R, Braasch J, Dugan J (2000). «Management of Hilar Cholangiocarcinoma: Comparison of an American and a Japanese Experience». Ann Surg. 232 (2): 166–74. PMC 1421125. PMID 10903592. doi:10.1097/00000658-200008000-00003
- Rajagopalan V, Daines W, Grossbard M, Kozuch P (2004). «Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1». Oncology (Williston Park). 18 (7): 889–96. PMID 15255172
- Su C, Tsay S, Wu C, Shyr Y, King K, Lee C, Lui W, Liu T, P'eng F (1996). «Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma». Ann Surg. 223 (4): 384–94. PMC 1235134. PMID 8633917. doi:10.1097/00000658-199604000-00007
- C. B. Rosen; J. K. Heimbach; G. J. Gores (2008). «Surgery for cholangiocarcinoma: the role of liver transplantation». The Official Journal of the International Hepato Pancreato Biliary Association. 10 (3): 186–9. PMC 2504373. PMID 18773052. doi:10.1080/13651820801992542
- Heimbach JK, Gores GJ, Haddock MG, et al. (dezembro de 2006). «Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma». Transplantation. 82 (12): 1703–7. PMID 17198263. doi:10.1097/01.tp.0000253551.43583.d1
- Kuhlmann, Jan B.; Blum, Hubert E. (maio de 2013). «Locoregional therapy for cholangiocarcinoma». Current Opinion in Gastroenterology. 29 (3): 324–8. ISSN 0267-1379. PMID 23337933. doi:10.1097/MOG.0b013e32835d9dea
- Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K (2000). «Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma». Int J Radiat Oncol Biol Phys. 46 (3): 581–7. PMID 10701737. doi:10.1016/S0360-3016(99)00472-1
- Alden M, Mohiuddin M (1994). «The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer». Int J Radiat Oncol Biol Phys. 28 (4): 945–51. PMID 8138448. doi:10.1016/0360-3016(94)90115-5
- González González D, Gouma D, Rauws E, van Gulik T, Bosma A, Koedooder C (1999). «Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma». Ann Oncol. 10 (Suppl 4): 215–20. PMID 10436826. doi:10.1023/A:1008339709327
- Pitt H, Nakeeb A, Abrams R, Coleman J, Piantadosi S, Yeo C, Lillemore K, Cameron J (1995). «Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival». Ann Surg. 221 (6): 788–97; discussão em 797–8. PMC 1234714. PMID 7794082. doi:10.1097/00000658-199506000-00017
- Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T (2002). «Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma». Cancer. 95 (8): 1685–95. PMID 12365016. doi:10.1002/cncr.10831
- Vauthey J, Blumgart L (1994). «Recent advances in the management of cholangiocarcinomas». Semin. Liver Dis. 14 (2): 109–14. PMID 8047893. doi:10.1055/s-2007-1007302
- Glimelius B, Hoffman K, Sjödén P, Jacobsson G, Sellström H, Enander L, Linné T, Svensson C (1996). «Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer». Ann Oncol. 7 (6): 593–600. PMID 8879373. doi:10.1093/oxfordjournals.annonc.a010676
- Choi C, Choi I, Seo J, Kim B, Kim J, Kim C, Um S, Kim J, Kim Y (2000). «Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas». Am J Clin Oncol. 23 (4): 425–8. PMID 10955877. doi:10.1097/00000421-200008000-00023
- Park J, Oh S, Kim S, Kwon H, Kim J, Jin-Kim H, Kim Y (2005). «Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study». Jpn J Clin Oncol. 35 (2): 68–73. PMID 15709089. doi:10.1093/jjco/hyi021
- Giuliani F, Gebbia V, Maiello E, Borsellino N, Bajardi E, Colucci G (2006). «Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)». Ann Oncol. 17 (Suppl 7): vii73–7. PMID 16760299. doi:10.1093/annonc/mdl956
- Bhargava P, Jani C, Savarese D, O'Donnell J, Stuart K, Rocha Lima C (2003). «Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report». Oncology (Williston Park). 17 (9 Suppl 8): 23–6. PMID 14569844
- Knox J, Hedley D, Oza A, Feld R, Siu L, Chen E, Nematollahi M, Pond G, Zhang J, Moore M (2005). «Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial». J Clin Oncol. 23 (10): 2332–8. PMID 15800324. doi:10.1200/JCO.2005.51.008
- Philip P, Mahoney M, Allmer C, Thomas J, Pitot H, Kim G, Donehower R, Fitch T, Picus J, Erlichman C (2006). «Phase II study of erlotinib in patients with advanced biliary cancer». J Clin Oncol. 24 (19): 3069–74. PMID 16809731. doi:10.1200/JCO.2005.05.3579
- Bonet Beltrán M, Allal AS, Gich I,; et al. (2012). «Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies». Cancer Treat Rev. 38 (2): 111–119. PMID 21652148. doi:10.1016/j.ctrv.2011.05.003
- Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF (2016). «Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling». American Society of Clinical Oncology Educational Book. 36 (36): e194–e203. PMID 27249723. doi:10.1200/EDBK_160831
- Yamamoto M, Takasaki K, Yoshikawa T (1999). «Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma». Japanese Journal of Clinical Oncology. 29 (3): 147–50. PMID 10225697. doi:10.1093/jjco/29.3.147
- Farley D, Weaver A, Nagorney D (1995). «"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention». Mayo Clin Proc. 70 (5): 425–9. PMID 7537346. doi:10.4065/70.5.425
- Grove MK, Hermann RE, Vogt DP, Broughan TA (1991). «Role of radiation after operative palliation in cancer of the proximal bile ducts». Am J Surg. 161 (4): 454–58. PMID 1709795. doi:10.1016/0002-9610(91)91111-U
- Estudos de resultados cirúrgicos em colangiocarcinoma distal incluem:
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406. PMID 8857851. doi:10.1097/00000658-199610000-00005
- Estudos de desfecho em colangiocarcinoma intra-hepático incluem:
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406. PMID 8857851. doi:10.1097/00000658-199610000-00005
- As estimativas de sobrevida após cirurgia para colangiocarcinoma peri-hilar incluem:
- Burke E, Jarnagin W, Hochwald S, Pisters P, Fong Y, Blumgart L (1998). «Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system». Ann Surg. 228 (3): 385–94. PMC 1191497. PMID 9742921. doi:10.1097/00000658-199809000-00011
- Kaya M, de Groen P, Angulo P, Nagorney D, Gunderson L, Gores G, Haddock M, Lindor K (2001). «Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience». Am J Gastroenterol. 96 (4): 1164–9. PMID 11316165. doi:10.1111/j.1572-0241.2001.03696.x
- Nakeeb A, Tran K, Black M, Erickson B, Ritch P, Quebbeman E, Wilson S, Demeure M, Rilling W, Dua K, Pitt H (2002). «Improved survival in resected biliary malignancies». Surgery. 132 (4): 555–63; discussão em 563–4. PMID 12407338. doi:10.1067/msy.2002.127555
- Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (dezembro de 2002). «Changing international trends in mortality rates for liver, biliary and pancreatic tumours». Journal of Hepatology. 37 (6): 806–13. PMID 12445422. doi:10.1016/S0168-8278(02)00297-0
- Landis S, Murray T, Bolden S, Wingo P (1998). «Cancer statistics, 1998». CA Cancer J Clin. 48 (1): 6–29. PMID 9449931. doi:10.3322/canjclin.48.1.6
- Vauthey JN, Blumgart LH (maio de 1994). «Recent advances in the management of cholangiocarcinomas». Seminars in Liver Disease. 14 (2): 109–14. PMID 8047893. doi:10.1055/s-2007-1007302
- Múltiplos estudos independentes documentaram um aumento constante na incidência mundial de colangiocarcinoma. Alguns artigos de periódicos relevantes incluem:
- Patel T (maio de 2002). «Worldwide trends in mortality from biliary tract malignancies». BMC Cancer. 2 (10). PMC 113759. PMID 11991810. doi:10.1186/1471-2407-2-10
- Patel T (maio de 2002). «Worldwide trends in mortality from biliary tract malignancies». BMC Cancer. 2 (10). PMC 113759
- Burke E, Jarnagin W, Hochwald S, Pisters P, Fong Y, Blumgart L (1998). «Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system». Ann Surg. 228 (3): 385–94. PMC 1191497
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406
- Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J (1996). «Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors». Ann Surg. 224 (4): 463–73; discussão em 473–5. PMC 1235406
wkhealth.com
meta.wkhealth.com
- Heimbach JK, Gores GJ, Haddock MG, et al. (dezembro de 2006). «Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma». Transplantation. 82 (12): 1703–7. PMID 17198263. doi:10.1097/01.tp.0000253551.43583.d1
worldcat.org
- «Role of Bacteria in Oncogenesis». 23 (4). 2010: 837–857. ISSN 0893-8512. PMC 2952975. PMID 20930075. doi:10.1128/CMR.00012-10
- Kuhlmann, Jan B.; Blum, Hubert E. (maio de 2013). «Locoregional therapy for cholangiocarcinoma». Current Opinion in Gastroenterology. 29 (3): 324–8. ISSN 0267-1379. PMID 23337933. doi:10.1097/MOG.0b013e32835d9dea